After Nasdaq Uplisting, PharmaCyte Biotech Looks Ready to Rumble

Published on September 7, 2021

There's no denying that PharmaCyte Biotech (PMCB) stock has lost much of its value over the years. However, recent developments could catalyze a price...

Continue reading on website
Other news

Top 5 Tips to Successfully Begin Investing in SMBs

September 7, 2021
For investors focusing on the B2B market, there are many benefits to be had by turning their attention to the SMB sector as well.

Looking for Growth Stocks? These 3 Are Great Buys

September 7, 2021
After a rotation into value stocks earlier this year, growth stocks have rebounded and are showing bullish momentum due to a strong economy and the tr...